Changes in myocardial iron content following administration of intravenous iron (Myocardial‐IRON): Study design

Treatment with intravenous ferric carboxymaltose (FCM) has been shown to improve symptoms, functional capacity, and quality of life in patients with heart failure and iron deficiency. However, the underlying mechanisms for these beneficial effects remain undetermined. The aim of this study is to qua...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cardiol
Main Authors: Miñana, Gema, Cardells, Ingrid, Palau, Patricia, Llàcer, Pau, Fácila, Lorenzo, Almenar, Luis, López‐Lereu, Maria Pilar, Monmeneu, Jose V., Amiguet, Martina, González, Jessika, Serrano, Alicia, Montagud, Vicente, López‐Vilella, Raquel, Valero, Ernesto, García‐Blas, Sergio, Bodí, Vicent, de la Espriella‐Juan, Rafael, Sanchis, Juan, Chorro, Francisco J., Bayés‐Genís, Antoni, Núñez, Julio
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley Periodicals, Inc. 2018
Assuntos:
Trial Designs
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6489786/
https://ncbi.nlm.nih.gov/pubmed/29607528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22956
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados